Moreover, leucine synergizes with PDE5 inhibitors to exert amplifying downstream effects of AMPK and Sirt1 activation on glucose and fat metabolism as well as reversal of hepatic steatosis and inflammation in vitro and in vivo [22]. The gene discussed is SIRT1; the disease is Hepatic steatosis.